Arab Health to showcase UK investment potential for Gulf boom

Arab Health to showcase UK investment potential for Gulf boom

Arab Health 2024 opens with a twist as the booming home market triggers growing interest in investing in the global healthcare sector, including the state-dominated UK NHS, which will be showcased at this week's event.

While domestic healthcare markets are rapidly developing within Gulf Co-operation Council countries, cash-rich investment funds are looking to life sciences, pharmaceutical and healthcare assets in the UK, the US and Europe.

Current Health Expenditure (CHE) in the GCC is projected to reach $135.5 billion in 2027, an increase of 5.4 per cent from 2022, according to Aspen Capital.

Jonathan Evans, director at the Association of British HealthTech Industries, noted the significant investments coming from GCC countries into Britain.

“In UK HealthTech alone, there are in the region of 4,500 companies. Add to that the thousands of pharmaceutical businesses and ancillary healthcare companies, and you have a huge ecosystem that will be looking for investment, so I would imagine we will see plenty more deal-making in the years ahead,” he told The National.